Cargando…
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359430/ https://www.ncbi.nlm.nih.gov/pubmed/33455021 http://dx.doi.org/10.1111/bju.15341 |
| _version_ | 1783737549374619648 |
|---|---|
| author | Tulchiner, Gennadi Brunner, Andrea Schmidinger, Manuela Staudacher, Nina Orme, Jacob J. Thurnher, Martin Horninger, Wolfgang Culig, Zoran Pichler, Renate |
| author_facet | Tulchiner, Gennadi Brunner, Andrea Schmidinger, Manuela Staudacher, Nina Orme, Jacob J. Thurnher, Martin Horninger, Wolfgang Culig, Zoran Pichler, Renate |
| author_sort | Tulchiner, Gennadi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8359430 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83594302021-08-17 CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma Tulchiner, Gennadi Brunner, Andrea Schmidinger, Manuela Staudacher, Nina Orme, Jacob J. Thurnher, Martin Horninger, Wolfgang Culig, Zoran Pichler, Renate BJU Int Research Communications John Wiley and Sons Inc. 2021-02-07 2021-07 /pmc/articles/PMC8359430/ /pubmed/33455021 http://dx.doi.org/10.1111/bju.15341 Text en © 2021 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Research Communications Tulchiner, Gennadi Brunner, Andrea Schmidinger, Manuela Staudacher, Nina Orme, Jacob J. Thurnher, Martin Horninger, Wolfgang Culig, Zoran Pichler, Renate CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| title | CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| title_full | CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| title_fullStr | CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| title_full_unstemmed | CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| title_short | CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| title_sort | cmtm6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma |
| topic | Research Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359430/ https://www.ncbi.nlm.nih.gov/pubmed/33455021 http://dx.doi.org/10.1111/bju.15341 |
| work_keys_str_mv | AT tulchinergennadi cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT brunnerandrea cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT schmidingermanuela cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT staudachernina cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT ormejacobj cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT thurnhermartin cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT horningerwolfgang cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT culigzoran cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma AT pichlerrenate cmtm6expressionasapotentialbiomarkerforimmunotherapyinmetastaticrenalcellcarcinoma |